transthyretin amyloidosis

GPTKB entity

Statements (68)
Predicate Object
gptkbp:instance_of gptkb:neurodegenerative_diseases
gptkbp:associated_with gptkb:familial_amyloid_cardiomyopathy
gptkb:familial_amyloid_polyneuropathy
gptkb:cardiac_amyloidosis
aging
hereditary factors
gptkbp:caused_by transthyretin protein misfolding
gptkbp:clinical_trial gptkb:depression
anxiety
dizziness
fatigue
nausea
sleep disturbances
weight loss
abdominal pain
dry eyes
vomiting
diarrhea
hearing loss
joint pain
muscle weakness
constipation
dry mouth
visual impairment
arrhythmias
shortness of breath
weight gain
numbness
peripheral neuropathy
carpal tunnel syndrome
tingling sensations
urinary incontinence
muscle cramps
skin rashes
skin changes
swelling in legs
brittle nails
gastrointestinal issues
autonomic dysfunction
erectile dysfunction
bradycardia
thinning hair
joint stiffness
vision changes
sweating abnormalities
fainting spells
puffy face
thickened tongue
gptkbp:diagnosis genetic testing
biopsy
gptkbp:first_described_by gptkb:1952
https://www.w3.org/2000/01/rdf-schema#label transthyretin amyloidosis
gptkbp:prevalence rare disease
gptkbp:research_areas gptkb:Genetics
clinical trials
pathology
treatment options
gptkbp:risk_factor family history
certain ethnic groups
mutations in TTR gene
gptkbp:symptoms heart failure
carpal tunnel syndrome
neuropathy
gptkbp:treatment gptkb:diflunisal
gptkb:tafamidis
liver transplantation
gptkbp:bfsParent gptkb:tafamidis
gptkbp:bfsLayer 7